Eli Lilly News

Two Habitat homes are now finished and the homeowners will receive the keys to their new homes.

The IPKat can now reveal that leave to appeal to the House of Lords has been refused in Eli Lilly and Company and others v 8PM Chemist Limited .

Eli Lilly and Co., which already has paid more than $1 billion to settle legal claims over the side effects of its top-selling drug, Zyprexa, now faces another protracted legal battle over whether it improperly ...

Byetta is a rising star for Amylin and its partner, Eli Lilly and Co. The two companies split revenues, which were $650.2 million last year.

A biotech startup with Indianapolis roots has raised another $25 million in venture funding to help it develop a new migraine drug it licensed two years ago from Eli Lilly and Co.

'If you perceive you need something new and different in the way of flea control, you do have new choices this season,' says Dr.

A federal judge in New York is urging Eli Lilly and Co. to settle a multibillion-dollar lawsuit filed by insurance companies, unions and others who claim the pharmaceutical giant overpriced its top-selling drug ...

The drug at the center of a looming power struggle between billionaire investor Carl Icahn and Amylin Pharmaceuticals treats one of the largest-growing epidemics in the world - diabetes.

A Lake Havasu City couple who ran a company that allegedly imported Indian-made knockoffs of popular prescription drugs and sold them as brand-name U.S. drugs has been indicted by a federal grand jury, the U.S. ...

Eli Lilly & Co. lost an appeal to limit potential damages in a lawsuit filed by Canadian patients who claimed they developed diabetes after using its Zyprexa schizophrenia drug.

Feeling depressed? Ask your doctor about Cymbalta. Growing anxious? Ask about Cymbalta for that, too.

For the second time in three days, the Food and Drug Administration has delayed making a decision on drugs that it had put on a fast track.

A development-stage drug company doing its research and development work in the Triangle has landed $25 million in series B financing to take its lead compound through mid-stage human trials.

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

New post: Director of business development at the Center for the Business of Life Sciences at Indiana University Kelley School of Business.

Following Thursday and Friday's precipitous selloff in the equity market - and the last month's for that matter - I once again found inspiration to look elsewhere for investment opportunities.

Drug maker Eli Lilly and Co. will pay $64,400 to settle a lawsuit accusing the company of withholding severance pay to force a longtime employee to withdraw a discrimination charge.

Cymbalta has been racking up U.S. government approvals for a variety of uses since it was introduced as an anti-depressant in 2004, healthcare analysts say.

If you were looking for help from the economic front or from the oil patch today to help out the market, that wasn't in the cards.

Eli Lilly and Co and Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion supporting the approval of ...